|
|
|
|
LEADER |
02637nam a22005535i 4500 |
001 |
978-3-642-35161-7 |
003 |
DE-He213 |
005 |
20151204144814.0 |
007 |
cr nn 008mamaa |
008 |
131126s2013 gw | s |||| 0|eng d |
020 |
|
|
|a 9783642351617
|9 978-3-642-35161-7
|
024 |
7 |
|
|a 10.1007/978-3-642-35161-7
|2 doi
|
040 |
|
|
|d GrThAP
|
050 |
|
4 |
|a TS155-TS194
|
072 |
|
7 |
|a KJMV
|2 bicssc
|
072 |
|
7 |
|a BUS087000
|2 bisacsh
|
082 |
0 |
4 |
|a 658.5
|2 23
|
245 |
1 |
0 |
|a Leading Pharmaceutical Operational Excellence
|h [electronic resource] :
|b Outstanding Practices and Cases /
|c edited by Thomas Friedli, Prabir Basu, Daniel Bellm, Jürgen Werani.
|
264 |
|
1 |
|a Berlin, Heidelberg :
|b Springer Berlin Heidelberg :
|b Imprint: Springer,
|c 2013.
|
300 |
|
|
|a IX, 541 p. 263 illus.
|b online resource.
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
347 |
|
|
|a text file
|b PDF
|2 rda
|
505 |
0 |
|
|a Part A - Introduction -- Part B - Leading Operational Excellence - Outstanding Practices -- Part C - Leading Operational Excellence - Outstanding Leadership -- Part D - Gaining the Future.
|
520 |
|
|
|a Achieving operational excellence is a challenge for the pharmaceutical industry, with many companies setting successful examples time and again. This book presents such leading practices for managing operational excellence throughout the pharmaceutical industry. Based on the St.Gallen OPEX Model the authors describe the current status of OPEX and the future challenges that have to be dealt with. The ample theoretical background is complemented hand-in-hand by case studies contributed by authors from leading pharmaceutical companies.
|
650 |
|
0 |
|a Business.
|
650 |
|
0 |
|a Management.
|
650 |
|
0 |
|a Leadership.
|
650 |
|
0 |
|a Production management.
|
650 |
|
0 |
|a Operations research.
|
650 |
|
0 |
|a Decision making.
|
650 |
|
0 |
|a Pharmaceutical technology.
|
650 |
1 |
4 |
|a Business and Management.
|
650 |
2 |
4 |
|a Operations Management.
|
650 |
2 |
4 |
|a Business Strategy/Leadership.
|
650 |
2 |
4 |
|a Pharmaceutical Sciences/Technology.
|
650 |
2 |
4 |
|a Operation Research/Decision Theory.
|
650 |
2 |
4 |
|a Management.
|
700 |
1 |
|
|a Friedli, Thomas.
|e editor.
|
700 |
1 |
|
|a Basu, Prabir.
|e editor.
|
700 |
1 |
|
|a Bellm, Daniel.
|e editor.
|
700 |
1 |
|
|a Werani, Jürgen.
|e editor.
|
710 |
2 |
|
|a SpringerLink (Online service)
|
773 |
0 |
|
|t Springer eBooks
|
776 |
0 |
8 |
|i Printed edition:
|z 9783642351600
|
856 |
4 |
0 |
|u http://dx.doi.org/10.1007/978-3-642-35161-7
|z Full Text via HEAL-Link
|
912 |
|
|
|a ZDB-2-SBE
|
950 |
|
|
|a Business and Economics (Springer-11643)
|